Navigation Links
Fuse Science Round II Research Offers Major Advancements in Delivery of Active Pharmaceutical Ingredients
Date:6/4/2013

d into the human body." 

Insulin, one of the compounds previously analyzed, is a reliable proof of principle for the technology.  Because it is such a large molecule, and a protein, it has been traditionally very difficult to deliver through the skin unless it was given via an injection.  During this study, it passed through even at low concentrations in the Company's proprietary formulation. 

In addition, two other large-market drugs Estradiol, used to treat the symptoms of menopause and Paclitaxel, a prescription cancer drug, were tested.  It is Fuse's hypothesis, based on the success of their research, that they will be successful in the delivery of therapeutic doses of each, within their matrix, in a simple roll-on application. 

The primary benefits that may develop from these studies are:

  • Enhanced delivery option for complex API's
  • Improved bio-availability or enhanced absorption in the body
  • Stronger product efficacy
  • Enhanced ease of use (A simple roll-on application)
  • Expansion of therapeutic options for acute, rapid onset conditions
  • Data from these preliminary research studies show that with little requirement for optimization, the technology can provide for the transdermal delivery of drugs at clinically relevant doses for the treatment of a wide variety of ailments and diseases.  Most compounds showed improvement of delivery over each time-point during the course of the study.  The lack of plateaus would suggest that delivery improves with time and can be sustained for periods much greater than twenty-four hours. 

    This latest research is particularly relevant to the active licensing and M&A efforts of the company.

    The full Round II Research report can be found by visiting the "Clinical Research" section of the Fuse Science Investor Relations page here: 

    SOURCE Fuse Science, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. BioMed Realty And Wexford Science & Technology Complete Merger
    2. PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition
    3. Lilly Statement on Indiana Biosciences Research Institute
    4. Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference
    5. Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Companys Drug Development Pipeline
    6. Pressure BioSciences, Inc. to Present at the Marcum MicroCap Conference
    7. BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference
    8. Record Use of At-the-Market (ATM) Offerings Continues in 2013 with $161 Million Raised by U.S. Life Sciences Companies in First Quarter, Reports Brinson Patrick
    9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
    10. Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
    11. Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
    (Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
    (Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
    Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
    ... Part D beneficiaries who enter the "donut hole," where ... prescription costs, are twice as likely to discontinue  their ... or generic medications, a new study published today in ... The study conducted by researchers from Harvard ...
    ... Aug. 16, 2011 BD (Becton, Dickinson and Company) ... technology company, today announced the completion of its acquisition ... the PhaSeal® System, the leading closed-system drug transfer device ... packaged in vials.  The acquisition expands the scope of ...
    Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3BD Completes Acquisition of Carmel Pharma 2BD Completes Acquisition of Carmel Pharma 3
    (Date:7/9/2014)... OH, July 10, 2014 -- The World Health Organization ... minutes of moderate to vigorous physical activity (MVPA) each ... of their MVPA during school hours. Therefore, it ... hours would increase MVPA. In a new study ... , researchers confirmed that time spent outdoors after school ...
    (Date:7/9/2014)... Perelman School of Medicine at the University of Pennsylvania ... received an $8 million grant from the National Cancer ... therapy (PDT) in patients with malignant pleural mesothelioma, a ... itself in the lining of the lungs and is ... will fund a clinical trial and additional studies looking ...
    (Date:7/9/2014)... researchers have uncovered mutations in a cell-signaling pathway that ... may expand treatments for patients because drugs targeting some ... in clinical trials. , Reporting July 9 in ... including researchers at Washington University School of Medicine in ... tumors from 230 patients with lung adenocarcinoma. , "This ...
    (Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
    (Date:7/9/2014)... DALLAS July 9, 2014 There has been ... at UT Southwestern Medical Center using MyChart, the online, ... radiology results, communicate with their healthcare providers, schedule appointments, ... number of patients actively using MyChart each ... each year increased more than 10-fold, according to a ...
    Breaking Medicine News(10 mins):Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3
    ... conducted by the American Institute for Cancer Research (AICR), ... cells, secreting hormones and other growth factors into the ... the popular belief that fat is an inert substance. ... levels of these hormones and growth factors play a ...
    ... patients coming to Queensland Public hospital will receive free ... to quit smoking. This free nicotine replacement program will ... which is one of the leading cause of preventable ... the systems from head to foot. Cigarette smoke contains ...
    ... Professor Geetanjali Dabral Datta and her research team from ... disparities occur in cervical cancer screening for women.// Cervical ... which proves to be a very useful and sensitive ... cervical cancer is easily curable compared to late stage ...
    ... that cold and flu drugs containing pseudoephedrine will be banned ... limit illegal manufacturing of such drugs. // ,This new ... in Queensland. Pharmacists have been asked to ensure that unknown ... out if their need is genuine. Pseudoephedrine is often used ...
    ... that every patient referral from a GP in England would ... end // of this month. ,But ministers have admitted ... are available - barely 2.7 per cent of referrals were ... that between October 2004 and September 2005, about 9.9 million ...
    ... or benefit analysis it has been found that unless heart ... farmed salmon // . ,The reasoning put forth is ... acids it also has a large amount of chemical contaminants. ... of cancer, memory impairment and neurobehavioral changes in children. ...
    Cached Medicine News:Health News:GP's online referral scheme in UK 'a national IT disaster' 2
    ... Portex® ULTRAperc® Percutaneous Dilation Tracheostomy ... of a tracheostomy tube using ... by means of a single-stage ... with or without the Portex® ...
    ... features a patented Per-fit™ flexible PVC tube ... low-profile cuff specifically designed to reduce insertion ... patients anatomy. The kit s unique obturator/dilator ... snugly, allowing for an easier transition through ...
    ... Each kit features a patented Per-fit™ flexible ... and a low-profile cuff specifically designed to ... to the patients anatomy. The kit s ... the tube snugly, allowing for an easier ...
    ... Self-contained kits provide convenience and cost ... tracheostomy care trays offer a variety of ... and management of the tracheostomized patient. , ... trays, and trays with disposable inner cannula ...
    Medicine Products: